AF
LUNG icon

Amalgamated Financial’s Pulmonx LUNG Stock Holding History

Amalgamated Financial’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$105K Buy
+4,251
New +$110K ﹤0.01% 2132

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Amalgamated Financial's LUNG Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Pulmonx (LUNG) in Q1 2022: 4,251 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #2132 among its holdings.

109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

  • Amalgamated Financial held 4,251 shares of Pulmonx worth $105K as of Q1 2022.
  • Pulmonx was a new Amalgamated Financial position in Q1 2022.
  • Pulmonx made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2132 holding.
  • 109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.